Variables | Attrition n (%) | AHR (95% CI) |
---|---|---|
Mental health | ||
Unexposed | 1750 (79.6) | 1.2 (1.1, 1.4) |
Exposed | 1063 (48.4) | Ref |
Age (IQR) | 31.75 (11.13) | 0.9 (0.99, 1.0) |
BaseCD4count (IQR) | 220.51 (760.59) | 0.9 (0.95, 1.0) |
Baseline WHO clinical | ||
WHO stage [I] | 298 (13.9) | Ref |
WHO stage [II] | 421 (19.6) | 1.1 (0.9, 1.3) |
WHO stage [III] | 1042 (48.5) | 1.2 (1.01, 1.4) |
WHO stage [IV] | 386 (18) | 1.5 (1.2, 1.8) |
CTM prophylaxis | ||
(No) | 314 (14.3) | 1.2 (1.01, 1.3) |
Yes | 1884 (85.7) | Ref |
INH prophylaxis | 445 (20.2) | 0.2 (0.14, 0.2) |
(Yes) | ||
No | 1753 (79.8) | Ref |
TB Coinfection | ||
(Yes) | 455 (20.7) | Ref |
No | 1743 (79.3) | 0.7 (0.6, 0.7) |
Gender | ||
Female | 1135 (51.6) | Ref |
Male | 1063 (48.4) | 1.2 (1.1, 1.3) |
LowestCD4 (IQR) | 164.05 (163.07) | 0.9 (0.9, 0.99) |
Regimen Substitution (No) | 1845 (83.9) | 0.14 (0.12, 0.2) |
Substitution (yes) | 353 (16.1) | Ref |
Baseline functional status | ||
Working | 1135 (51.6) | 0.6 (0.5, 0.7) |
Ambulatory | 726 (33.0) | 0.5 (0.4, 0.5) |
Bedridden | 280 (12.7) | Ref |
ART Enrolment year | ||
2005–2007 | 610 (28) | Ref |
2008–2010 | 830 (38.2) | 1.22 (1.1, 1.36) |
2011–2013 | 435 (20) | 1.5 (1.31, 1.73) |
2014–2017 | 300 (13.8) | 2.3 (1.96 2.75) |